Skip to main content
. 2021 Aug 9;22(16):8573. doi: 10.3390/ijms22168573

Table 2.

Isobolographic interactions between CDDP and CAM at the fixed-ratio combination of 1:1 in four cancer cell lines (MCF7, T47D, MDA-MB-231, and MDA-MB-468) measured in vitro by the MTT assay. Results are presented as median inhibitory concentrations (IC50 values in μg/mL ± S.E.M.) for two-drug mixtures, determined either experimentally (IC50 mix) or theoretically calculated (IC50 add) from the equations of additivity [32,33], blocking proliferation in 50% of tested cells in four cancer cell lines (MCF7, T47D, MDA-MB-231, and MDA-MB-468) measured in vitro by the MTT assay.

Cell Line IC50 mix (μg/mL) n mix L IC50 add (μg/mL) n add U IC50 add (μg/mL) n add p-Value Type of Interaction
MCF7 32.483 ± 1.508 90 4.314 ± 3.781 140 17.573 ± 4.743 140 0.0032 ** antagonism
T47D 19.112 ± 3.055 90 3.478 ± 2.515 140 14.158 ± 3.404 140 0.2799 tendency towards antagonism
MDA-MB-231 21.352 ± 1.980 72 3.638 ± 2.840 158 11.304 ± 3.813 158 0.0203 * antagonism
MDA-MB-468 15.713 ± 1.513 90 3.671 ± 2.391 158 12.927 ± 3.155 158 0.4268 tendency towards antagonism

nmix—total number of items used at those concentrations whose expected anti-proliferative effects ranged between 16% and 84% (i.e., 4 and 6 probits) for the experimental mixture; n add—total number of items calculated for the additive mixture of the drugs examined; L—IC50 add value calculated from the equation for the lower line of additivity; U—IC50 add value calculated from the equation for the upper line of additivity. Statistical evaluation of data was performed with unpaired t-test with Welch’s correction. * p < 0.05 and ** p < 0.01 vs. the respective IC50 mix value.